GlassScriptPhysician profile
Anthony Thomas Pizzo
NPI 1679559918
$8,893.94
in general payments reported to CMS, 2019-2025
37 companies · $917 in 2025
The $917 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,065 · 2020: $1,376 · 2021: $2,361 · 2022: $1,768 · 2023: $949 · 2024: $457 · 2025: $917.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,323.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $2,981.52 | 2019-2025 | Amvia Edge, Biomonitor, Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $1,719.97 | 2019-2025 | Eluvia, Synergy, Ekosonic |
| Cvrx, INC. | $448.51 | 2020-2023 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $412.12 | 2020-2023 | Farxiga |
| W. L. Gore & Associates, INC. | $328.02 | 2019-2022 | |
| Abbott Laboratories | $309.86 | 2019-2022 | |
| Medtronic Vascular, INC. | $293.32 | 2019-2020 | |
| Inari Medical, INC. | $292.46 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $268.23 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $263.28 | 2021-2022 | |
| Cardiovascular Systems INC. | $224.19 | 2020-2022 | |
| Biosense Webster, INC. | $205.83 | 2021-2023 | Carto 3, Octaray Mapping Catheter |
| Stryker Corporation | $182.26 | 2025 | Flowtriever |
| Medtronic, INC. | $119.65 | 2021-2025 | Hawkone |
| Novartis Pharmaceuticals Corporation | $77.36 | 2021-2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $68.78 | 2019-2025 | Angiosculpt Cv Rx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $64.71 | 2021-2024 | Lifevest |
| Portola Pharmaceuticals, LLC | $61.51 | 2019-2020 | |
| Taiho Oncology, INC. | $55.90 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.39 | 2021-2023 | Jardiance |
| Medtronic USA, INC. | $53.97 | 2019 | |
| Cardinal Health 200 LLC | $46.90 | 2019 | |
| Amarin Pharma, INC. | $38.54 | 2020 | |
| Silk Road Medical, INC. | $38.01 | 2021-2022 | |
| Veryan Medical Incorporated | $36.84 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $36.45 | 2022 | |
| Braemar Manufacturing, LLC | $34.70 | 2019 | |
| Abiomed | $31.12 | 2021 | |
| Siemens Medical Solutions USA, INC. | $29.99 | 2022 | |
| Sanofi-Aventis U.S. LLC | $20.44 | 2019 | |
| Novo Nordisk INC | $16.91 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $14.47 | 2019 | |
| Alnylam Pharmaceuticals INC. | $13.49 | 2019 | |
| Shockwave Medical, INC | $13.48 | 2021 | |
| Astellas Pharma US INC | $12.97 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $12.79 | 2019 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Pizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.